Use of Bevacizumab in the Treatment of Metastatic Colorectal Cancer (mCRC) in Italy: an Observational Cohort Study
Phase of Trial: Phase IV
Latest Information Update: 05 Aug 2015
At a glance
- Drugs Bevacizumab (Primary) ; Antineoplastics
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms BEWARE
- Sponsors Roche
- 01 Jun 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 May 2013 Planned end date changed from 1 Sep 2013 to 1 May 2013 as reported by ClinicalTrials.gov.
- 07 Jun 2012 New trial record